Delayed CIN2 treatment does not increase cancer risk
1. In this target trial emulation, delayed treatment of cervical intraepithelial neoplasia grade 2 (CIN 2) was associated with a ...
1. In this target trial emulation, delayed treatment of cervical intraepithelial neoplasia grade 2 (CIN 2) was associated with a ...
1. In this cohort study, the quadrivalent human papillomavirus (HPV) vaccine provides strong, long-lasting protection against invasive cervical cancer, with ...
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study 1. In this cohort study, ...
1. In this individual-based modeling study, fewer cervical cancer screens for HPV-vaccinated women were the most cost-effective strategy. 2. Fewer ...
1. Punjab launched India’s first large-scale AI screening program for cancer and eye disease. 2. The initiative aims to perform ...
Lilly unveils TuneLab AI platform for biotechs On September 9, 2025, Eli Lilly officially unveiled TuneLab, a federated AI platform ...
1. Cadonilimab plus chemotherapy significantly improved progression-free survival in patients with persistent, recurrent, or metastatic cervical cancer. 2. Common grade ...
1. In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when ...
1. 5-year progression-free survival was increased in the induction chemotherapy group compared to standard chemoradiotherapy. 2. Patients in the induction ...
1. 36-month overall survival was significantly greater in the pembrolizumab-chemoradiotherapy group compared to placebo-chemoradiotherapy. 2. Grade 3 or higher adverse ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.